Publication | Closed Access

Repeated Botulinum Toxin Type A Injections for Refractory Overactive Bladder: Medium-Term Outcomes, Safety Profile, and Discontinuation Rates

UrologyVoiding DysfunctionFemale UrologySurgeryUrogynecologyMedium-term OutcomesMedicineRefractory Overactive BladderSafety Profile